|
🐜
|
RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN‐2, AND GAMMA‐INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS
9 auth.
D. Abramowicz,
L. Schandené,
M. Goldman,
A. Crusiaux,
P. Vereerstraeten,
L. Pauw,
...
J. Wybran,
E. Dupont,
C. Toussaint
|
8 |
1989 |
8
🐜
|
|
🐬
|
Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome.
E. Cogan,
L. Schandené,
A. Crusiaux,
P. Cochaux,
T. Velu,
M. Goldman
|
8 |
1994 |
8
🐬
|
|
🐬
|
Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patients
B. Byl,
I. Roucloux,
A. Crusiaux,
E. Dupont,
J. Devière
|
7 |
1993 |
7
🐬
|
|
🐜
|
Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells.
8 auth.
L. Schandené,
G. D. Prete,
Elie Cogan,
P. Stordeur,
A. Crusiaux,
Bernard Kennès,
...
Sergio Romagnani,
Michel Goldman
|
7 |
1996 |
7
🐜
|
|
🐜
|
Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.
8 auth.
L. Schandené,
P. Vandenbussche,
A. Crusiaux,
M. Alegre,
D. Abramowicz,
E. Dupont,
...
J. Content,
M. Goldman
|
7 |
1992 |
7
🐜
|
|
🐬
|
Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients.
B. Byl,
I. Roucloux,
A. Crusiaux,
E. Dupont,
J. Devière
|
6 |
1993 |
6
🐬
|
|
🐜
|
T helper type 2‐like cells and therapeutic effects of interferon‐γ in combined immunodeficiency with hypereosinophilia (Omenn's syndrome)
10 auth.
L. Schandené,
A. Ferster,
F. Mascart‐Lemone,
A. Crusiaux,
C. Gerard,
A. Marchant,
...
Myriam Lybin,
T. Velu,
E. Sariban,
M. Goldman
|
6 |
1993 |
6
🐜
|
|
🐜
|
Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis.
8 auth.
O. Moine,
J. Devière,
J. Devaster,
A. Crusiaux,
F. Durand,
J. Bernuau,
...
Michel Goldman,
J. Benhamou
|
6 |
1994 |
6
🐜
|
|
🐜
|
Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti–interleukin-2 receptor monoclonal antibody basiliximab
7 auth.
V. Baudouin,
A. Crusiaux,
E. Haddad,
L. Schandené,
M. Goldman,
C. Loirat,
...
D. Abramowicz
|
6 |
2003 |
6
🐜
|
|
🐬
|
Anaphylactic shock after retreatment with OKT3 monoclonal antibody.
D. Abramowicz,
A. Crusiaux,
M. Goldman
|
6 |
1992 |
6
🐬
|
